Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL

NCT03524235 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
CLL
Chronic Lymphocytic Leukemia
Lymphoma
Hodgkin Lymphoma

Interventions

RADIATION: Total Body Irradiation
PROCEDURE: Haploidentical Stem Cell Transplantation
BIOLOGICAL: CD56-Enriched Donor Lymphocyte Infusion
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: Rituximab

Sponsor

Noah Merin

Collaborators

[object Object]
[object Object]